News & Trends - Pharmaceuticals
Community pharmacies welcome professional services report
More than 1,000 community pharmacies now have received professional services income potential reports as part of the Pharmacy Guild of Australia’s Health Advice Plus program.
The program is a support service for member pharmacies who want to get started or need additional support to integrate and deliver successful health programs and services, Pharmacy Guild Group Executive Member Services and Innovation, Colm Maguire, said.
“The first step in the process is to access the Opportunity Analysis tool – provided free of charge for Guild members – which analyses the income potential from services for individual pharmacies,” he said.
“The online Opportunity Analysis tool provides a report that includes an estimate of untapped opportunity potential and establishes a performance
benchmarking mechanism to ensure this opportunity is secured as the pharmacy moves to a professional services model.”
The Opportunity Analysis report covers: 6CPA funded programs, fixed third party income, prescription and medication programs, as well as screening and testing services and is supported by an individual review session with a trained pharmacy coach, the Guild said.
The Health Advice Plus and Opportunity Analysis Program has been developed as a partnership between the Pharmacy Guild of Australia and instigo.
Key Findings
- 87 per cent of pharmacies have a private consultation room.
- 44 per cent of pharmacies are maximising their clinical Intervention potential.
- Only 28 per cent of pharmacies are maximising MedsChecks with an average of 12 a month.
- 56 per cent of pharmacies have not reached their DAA cap level.
- 72 per cent of pharmacies are currently providing vaccination services.
Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.
You may also like Government launches centre of research excellence in suicide prevention
News & Trends - Pharmaceuticals
Roche’s immunotherapy drug shows promising results for Australian patients with rare blood cancer
Pharma News: Roche’s immunotherapy drug has shown high response rates in patients with a rare form of blood cancer that […]
MoreNews & Trends - Pharmaceuticals
Government seals deal with industry for rare cancer therapy
Pharma News: Australian children and young adults diagnosed with high-risk neuroblastoma will continue to receive free access to a promising, […]
MoreNews & Trends - MedTech & Diagnostics
Abbott showcases leadless pacemaker system to local stakeholders
MedTech & Diagnostics News: Leadless pacemakers are promising alternatives to transvenous pacing. Abbott hosted a stakeholder event at the recent […]
MoreNews & Trends - Pharmaceuticals
Australian scientists pivotal in new drug class from BMS
Pharma News: The first new class of drug for schizophrenia in decades has been approved, offering a fresh approach by […]
More